Emmaus Life Sciences Inc (PK:EMMA)

Business Focus: Biotechnology & Medical Research

INK Ultra Money Free

Latest 10 SEC filings (by transaction date) for EMMA within the last 6 months [?]
Amended Filing      Footnote and/or Remark
As of 11:59pm ET May 26th, 2020
Filing
Date
Transaction
Date
Insider Name Ownership
Type
Securities Nature of transaction Volume or Value Price
May 22/20 May 21/20 Niihara Yutaka Direct Ownership Common stock, $0.001 par value P - Open market or private purchase 1,700 $1.37
May 22/20 May 20/20 Niihara Yutaka Direct Ownership Common stock, $0.001 par value P - Open market or private purchase 4,000 $1.40
May 20/20 May 18/20 Niihara Yutaka Direct Ownership Common stock, $0.001 par value P - Open market or private purchase 500 $1.35
May 18/20 May 15/20 Niihara Yutaka Direct Ownership Common stock, $0.001 par value P - Open market or private purchase 500 $1.29
May 18/20 May 14/20 Niihara Yutaka Direct Ownership Common stock, $0.001 par value P - Open market or private purchase 1,400 $1.29
May 14/20 May 13/20 Niihara Yutaka Direct Ownership Common stock, $0.001 par value P - Open market or private purchase 2,100 $1.26
May 14/20 May 12/20 Niihara Yutaka Direct Ownership Common stock, $0.001 par value P - Open market or private purchase 3,200 $1.32
May 11/20 May 8/20 Niihara Yutaka Direct Ownership Common stock, $0.001 par value P - Open market or private purchase 4,900 $1.27
May 11/20 May 7/20 Niihara Yutaka Direct Ownership Common stock, $0.001 par value P - Open market or private purchase 2,950 $1.25
May 7/20 May 6/20 Niihara Yutaka Direct Ownership Common stock, $0.001 par value P - Open market or private purchase 1,000 $1.30
Sign up or login above to see all SEC filings within the past 6 months.
Latest 10 SEC filings (by filing date) for EMMA within the last 6 months [?]
Amended Filing      Footnote and/or Remark
As of 11:59pm ET May 26th, 2020
Filing
Date
Transaction
Date
Insider Name Ownership
Type
Securities Nature of transaction Volume or Value Price
May 22/20 May 21/20 Niihara Yutaka Direct Ownership Common stock, $0.001 par value P - Open market or private purchase 1,700 $1.37
May 22/20 May 20/20 Niihara Yutaka Direct Ownership Common stock, $0.001 par value P - Open market or private purchase 4,000 $1.40
May 20/20 May 18/20 Niihara Yutaka Direct Ownership Common stock, $0.001 par value P - Open market or private purchase 500 $1.35
May 18/20 May 15/20 Niihara Yutaka Direct Ownership Common stock, $0.001 par value P - Open market or private purchase 500 $1.29
May 18/20 May 14/20 Niihara Yutaka Direct Ownership Common stock, $0.001 par value P - Open market or private purchase 1,400 $1.29
May 14/20 May 13/20 Niihara Yutaka Direct Ownership Common stock, $0.001 par value P - Open market or private purchase 2,100 $1.26
May 14/20 May 12/20 Niihara Yutaka Direct Ownership Common stock, $0.001 par value P - Open market or private purchase 3,200 $1.32
May 11/20 May 8/20 Niihara Yutaka Direct Ownership Common stock, $0.001 par value P - Open market or private purchase 4,900 $1.27
May 11/20 May 7/20 Niihara Yutaka Direct Ownership Common stock, $0.001 par value P - Open market or private purchase 2,950 $1.25
May 7/20 May 6/20 Niihara Yutaka Direct Ownership Common stock, $0.001 par value P - Open market or private purchase 1,000 $1.30
Sign up or login above to see all SEC filings within the past 6 months.
Sign up or login above to see the past 6 months of filings sorted by insider. .
Get holdings trends & enhanced insider charts in PDF now

Twitter

Search (past week) for $EMMA

Competitors

Competitors with Recent Insider Filings
Iqvia Holdings (N:IQV)
Seattle Genetics (OQ:SGEN)
Alnylam Pharmaceuticals (OQ:ALNY)